The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
B-F1RST: Assessment of novel blood-based biomarkers in patients with first-line advanced or metastatic NSCLC receiving atezolizumab monotherapy.
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly
 
Mark A. Socinski
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Research Funding - Pfizer (Inst)
 
Shaker R. Dakhil
No Relationships to Disclose
 
Niklas J. Mackler
Consulting or Advisory Role - Physician Resource Management (I)
 
Nadeem Ikhlaque
No Relationships to Disclose
 
Tarek Mekhail
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Research Funding - Genentech
 
Fabio Volterra
No Relationships to Disclose
 
Christian Antoine El Khoury
Employment - Quincy Medical Group
Stock and Other Ownership Interests - Bluebird Bio; Bristol-Myers Squibb; Celgene; Gilead Sciences; ION Pharma
Research Funding - Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Joan H. Schiller
Consulting or Advisory Role - Ariad; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; Genentech/Roche; Lilly; Merck; Oncogenex
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); Clovis Oncology (Inst); Genentech (Inst); Synta (Inst); Xcovery (Inst)
Other Relationship - Free to Breathe
 
Michaela L. Tsai
No Relationships to Disclose
 
Fadi Hayek
Stock and Other Ownership Interests - Abbvie; Genentech; Genmab; Geron; Merrimack; Takeda
Consulting or Advisory Role - bioTheranostics
 
Jeffrey D. Neidhart
No Relationships to Disclose
 
Brian Hunis
Stock and Other Ownership Interests - Gilead Sciences
 
Sylvia Hu
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Sarah M. Paul
Employment - Genentech
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech
 
David S. Shames
Employment - Genentech
 
See-Chun Phan
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Cindy Yun
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Genentech
 
Vamsidhar Velcheti
Honoraria - Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Merck; Novartis
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Foundation Medicine; Genentech; Genoptix; Merck
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai